ABEO
Abeona Therapeutics Inc.$5.58+0.04 (+0.81%)Prev Close$5.53·MCap$311.2M·P/E5.49·Vol793.3K·Yield—
▲
Buys (12M)
0
$0.00
▼
Sells (12M)
37
$4.64M
◆
Net Activity
Net Seller
$4.64M
●
Active Insiders
10
last 12 mo
Over the past 12 months, insider activity at Abeona Therapeutics Inc. (ABEO) has been exclusively selling, with 0 insider purchases totaling $0.00 and 37 insider sales totaling $4.64M. The most recent insider transaction was by O'Malley Brendan M. (officer: SVP, Chief Legal Officer), who sold $59.6K worth of shares on Jun 9, 2026. Abeona Therapeutics Inc. operates in the Healthcare sector, within the Biotechnology industry, with a market cap of $311.2M.
ABEO Insider Trading Activity
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Jun 9, 2026 | O'Malley Brendan M. | officer: SVP, Chief Legal Officer | Sell | 11,131 | $5.36 | $59.6K | 446,308 |
| Jun 9, 2026 | Vasanthavada Madhav | officer: Chief Commercial Officer | Sell | 9,620 | $5.36 | $51.5K | 308,901 |
| Jun 9, 2026 | Vazzano Joseph Walter | officer: Chief Financial Officer | Sell | 49,338 | $5.38 | $265.2K | 557,504 |
| Jun 9, 2026 | Seshadri Vishwas | director, officer: Chief Executive Officer | Sell | 56,344 | $5.36 | $301.9K | 1,405,995 |
| May 22, 2026 | Alvino Mark | director | Sell | 6,500 | $5.46 | $35.5K | 77,565 |
| May 15, 2026 | Crombez Eric | director | Sell | 26,143 | $5.53 | $144.6K | 37,313-41% |
| May 11, 2026 | Vasanthavada Madhav | officer: Chief Commercial Officer | Sell | 5,548 | $5.96 | $33.1K | 313,071 |
| Mar 31, 2026 | Seshadri Vishwas | director, officer: Chief Executive Officer | Sell | 29,985 | $4.38 | $131.5K | 1,430,423 |
| Mar 16, 2026 | Vazzano Joseph Walter | officer: Chief Financial Officer | Sell | 785 | $4.76 | $3.7K | 567,775 |
| Feb 4, 2026 | Silverstein Christine Berni | director | Sell | 20,070 | $5.09 | $102.2K | 137,722 |
| Feb 2, 2026 | Alland Leila | Director | Sell | 36,130 | $5.09 | $183.9K | 173,614 |
| Feb 2, 2026 | Alvino Mark | Director | Sell | 4,000 | $5.09 | $20.4K | 84,065 |
| Feb 2, 2026 | Crombez Eric | Director | Sell | 32,568 | $5.09 | $165.8K | 63,456-34% |
| Feb 2, 2026 | Wuchterl Donald A. | Director | Sell | 29,628 | $5.09 | $150.8K | 167,935 |
| Feb 2, 2026 | Silverstein Christine Berni | Director | Sell | 20,070 | $5.09 | $102.2K | 0 |
| Jan 26, 2026 | Vasanthavada Madhav | officer: Chief Commercial Officer | Sell | 12,610 | $5.29 | $66.7K | 318,619 |
| Jan 22, 2026 | O'Malley Brendan M. | SVP, Chief Legal Officer | Sell | 27,156 | $5.33 | $144.8K | 451,134 |
| Jan 22, 2026 | Seshadri Vishwas | director, officer: Chief Executive Officer | Sell | 139,664 | $5.33 | $744.5K | 1,460,408 |
| Jan 22, 2026 | Vazzano Joseph Walter | officer: Chief Financial Officer | Sell | 37,332 | $5.33 | $199.0K | 568,560 |
| Jan 21, 2026 | Alvino Mark | Director | Sell | 27,000 | $5.23 | $141.1K | 48,752-36% |
| Jan 20, 2026 | Vasanthavada Madhav | Chief Commercial Officer | Sell | 12,610 | $5.29 | $66.7K | 0 |
| Dec 29, 2025 | Seshadri Vishwas | Chief Executive Officer | Sell | 25,000 | $5.31 | $132.7K | 0 |
| Nov 13, 2025 | Alvino Mark | Director | Sell | 15,000 | $4.74 | $71.2K | 0 |
| Oct 16, 2025 | Seshadri Vishwas | Chief Executive Officer | Sell | 249 | $5.49 | $1.4K | 0 |
| Sep 29, 2025 | O'Malley Brendan M. | SVP, Chief Legal Officer | Sell | 9,366 | $5.39 | $50.5K | 0 |
| Sep 29, 2025 | Seshadri Vishwas | Chief Executive Officer | Sell | 44,274 | $5.31 | $234.9K | 0 |
| Sep 29, 2025 | Vazzano Joseph Walter | Chief Financial Officer | Sell | 9,035 | $5.39 | $48.7K | 0 |
| Sep 22, 2025 | O'Malley Brendan M. | SVP, Chief Legal Officer | Sell | 688 | $5.43 | $3.7K | 0 |
| Aug 15, 2025 | Vazzano Joseph Walter | Chief Financial Officer | Sell | 15,000 | $7.36 | $110.4K | 0 |
| Aug 14, 2025 | Crombez Eric | Director | Sell | 4,718 | $6.93 | $32.7K | 0 |
| Jul 22, 2025 | Vazzano Joseph Walter | Chief Financial Officer | Sell | 1,502 | $6.64 | $10.0K | 0 |
| Jul 9, 2025 | Charles Faith L. | Director | Sell | 10,738 | $5.86 | $62.9K | 0 |
| Jul 9, 2025 | O'Malley Brendan M. | SVP, Chief Legal Officer | Sell | 17,428 | $5.86 | $102.1K | 0 |
| Jul 9, 2025 | Seshadri Vishwas | Chief Executive Officer | Sell | 69,420 | $5.86 | $406.5K | 0 |
| Jul 9, 2025 | Silverstein Christine Berni | Director | Sell | 13,093 | $5.86 | $76.7K | 0 |
| Jul 9, 2025 | Vazzano Joseph Walter | Chief Financial Officer | Sell | 25,411 | $5.86 | $148.8K | 0 |
| Jul 8, 2025 | Wuchterl Donald A. | Director | Sell | 5,176 | $5.82 | $30.1K | 0 |
| Jun 6, 2025 | O'Malley Brendan M. | SVP, General Counsel | Sell | 10,470 | $6.76 | $70.8K | 0 |
| Jun 6, 2025 | Seshadri Vishwas | Chief Executive Officer | Sell | 50,676 | $6.76 | $342.6K | 0 |
| Jun 6, 2025 | Vazzano Joseph Walter | Chief Financial Officer | Sell | 17,795 | $6.76 | $120.3K | 0 |
| Jun 1, 2025 | Seshadri Vishwas | Chief Executive Officer | Sell | 885 | $6.24 | $5.5K | 0 |
| May 27, 2025 | Alvino Mark | Director | Sell | 2,000 | $6.38 | $12.8K | 0 |
| May 16, 2025 | Alvino Mark | Director | Sell | 8,000 | $5.68 | $45.4K | 0 |
| Mar 31, 2025 | Seshadri Vishwas | Chief Executive Officer | Sell | 25,000 | $4.78 | $119.5K | 0 |
| Mar 14, 2025 | Vazzano Joseph Walter | Chief Financial Officer | Sell | 685 | $5.29 | $3.6K | 0 |
| Mar 3, 2025 | O'Malley Brendan M. | SVP, General Counsel | Sell | 181 | $5.24 | $948.44 | 0 |
| Jan 29, 2025 | Alvino Mark | Director | Sell | 4,000 | $5.38 | $21.5K | 0 |
| Jan 21, 2025 | Alvino Mark | Director | Sell | 4,000 | $5.10 | $20.4K | 0 |
| Oct 16, 2024 | Seshadri Vishwas | Chief Executive Officer | Sell | 251 | $6.54 | $1.6K | 0 |
| Sep 28, 2024 | O'Malley Brendan M. | SVP, General Counsel | Sell | 6,579 | $5.89 | $38.8K | 0 |
Showing 1–50 of 112
1 / 3
ABEO Insider Buying Activity
The following table shows recent insider purchases of Abeona Therapeutics Inc. (ABEO) stock reported via SEC Form 4 filings.
No insider buying activity found for ABEO in the last 12 months.
ABEO Insider Selling Activity
The following table shows recent insider sales of Abeona Therapeutics Inc. (ABEO) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Jun 9, 2026 | O'Malley Brendan M. | officer: SVP, Chief Legal Officer | Sell | 11,131 | $5.36 | $59.6K | 446,308 |
| Jun 9, 2026 | Vasanthavada Madhav | officer: Chief Commercial Officer | Sell | 9,620 | $5.36 | $51.5K | 308,901 |
| Jun 9, 2026 | Vazzano Joseph Walter | officer: Chief Financial Officer | Sell | 49,338 | $5.38 | $265.2K | 557,504 |
| Jun 9, 2026 | Seshadri Vishwas | director, officer: Chief Executive Officer | Sell | 56,344 | $5.36 | $301.9K | 1,405,995 |
| May 22, 2026 | Alvino Mark | director | Sell | 6,500 | $5.46 | $35.5K | 77,565 |
| May 15, 2026 | Crombez Eric | director | Sell | 26,143 | $5.53 | $144.6K | 37,313-41% |
| May 11, 2026 | Vasanthavada Madhav | officer: Chief Commercial Officer | Sell | 5,548 | $5.96 | $33.1K | 313,071 |
| Mar 31, 2026 | Seshadri Vishwas | director, officer: Chief Executive Officer | Sell | 29,985 | $4.38 | $131.5K | 1,430,423 |
| Mar 16, 2026 | Vazzano Joseph Walter | officer: Chief Financial Officer | Sell | 785 | $4.76 | $3.7K | 567,775 |
| Feb 4, 2026 | Silverstein Christine Berni | director | Sell | 20,070 | $5.09 | $102.2K | 137,722 |
| Feb 2, 2026 | Alland Leila | Director | Sell | 36,130 | $5.09 | $183.9K | 173,614 |
| Feb 2, 2026 | Alvino Mark | Director | Sell | 4,000 | $5.09 | $20.4K | 84,065 |
| Feb 2, 2026 | Crombez Eric | Director | Sell | 32,568 | $5.09 | $165.8K | 63,456-34% |
| Feb 2, 2026 | Wuchterl Donald A. | Director | Sell | 29,628 | $5.09 | $150.8K | 167,935 |
| Feb 2, 2026 | Silverstein Christine Berni | Director | Sell | 20,070 | $5.09 | $102.2K | 0 |
| Jan 26, 2026 | Vasanthavada Madhav | officer: Chief Commercial Officer | Sell | 12,610 | $5.29 | $66.7K | 318,619 |
| Jan 22, 2026 | O'Malley Brendan M. | SVP, Chief Legal Officer | Sell | 27,156 | $5.33 | $144.8K | 451,134 |
| Jan 22, 2026 | Seshadri Vishwas | director, officer: Chief Executive Officer | Sell | 139,664 | $5.33 | $744.5K | 1,460,408 |
| Jan 22, 2026 | Vazzano Joseph Walter | officer: Chief Financial Officer | Sell | 37,332 | $5.33 | $199.0K | 568,560 |
| Jan 21, 2026 | Alvino Mark | Director | Sell | 27,000 | $5.23 | $141.1K | 48,752-36% |
| Jan 20, 2026 | Vasanthavada Madhav | Chief Commercial Officer | Sell | 12,610 | $5.29 | $66.7K | 0 |
| Dec 29, 2025 | Seshadri Vishwas | Chief Executive Officer | Sell | 25,000 | $5.31 | $132.7K | 0 |
| Nov 13, 2025 | Alvino Mark | Director | Sell | 15,000 | $4.74 | $71.2K | 0 |
| Oct 16, 2025 | Seshadri Vishwas | Chief Executive Officer | Sell | 249 | $5.49 | $1.4K | 0 |
| Sep 29, 2025 | O'Malley Brendan M. | SVP, Chief Legal Officer | Sell | 9,366 | $5.39 | $50.5K | 0 |
| Sep 29, 2025 | Seshadri Vishwas | Chief Executive Officer | Sell | 44,274 | $5.31 | $234.9K | 0 |
| Sep 29, 2025 | Vazzano Joseph Walter | Chief Financial Officer | Sell | 9,035 | $5.39 | $48.7K | 0 |
| Sep 22, 2025 | O'Malley Brendan M. | SVP, Chief Legal Officer | Sell | 688 | $5.43 | $3.7K | 0 |
| Aug 15, 2025 | Vazzano Joseph Walter | Chief Financial Officer | Sell | 15,000 | $7.36 | $110.4K | 0 |
| Aug 14, 2025 | Crombez Eric | Director | Sell | 4,718 | $6.93 | $32.7K | 0 |
| Jul 22, 2025 | Vazzano Joseph Walter | Chief Financial Officer | Sell | 1,502 | $6.64 | $10.0K | 0 |
| Jul 9, 2025 | Charles Faith L. | Director | Sell | 10,738 | $5.86 | $62.9K | 0 |
| Jul 9, 2025 | O'Malley Brendan M. | SVP, Chief Legal Officer | Sell | 17,428 | $5.86 | $102.1K | 0 |
| Jul 9, 2025 | Seshadri Vishwas | Chief Executive Officer | Sell | 69,420 | $5.86 | $406.5K | 0 |
| Jul 9, 2025 | Silverstein Christine Berni | Director | Sell | 13,093 | $5.86 | $76.7K | 0 |
| Jul 9, 2025 | Vazzano Joseph Walter | Chief Financial Officer | Sell | 25,411 | $5.86 | $148.8K | 0 |
| Jul 8, 2025 | Wuchterl Donald A. | Director | Sell | 5,176 | $5.82 | $30.1K | 0 |
| Jun 6, 2025 | O'Malley Brendan M. | SVP, General Counsel | Sell | 10,470 | $6.76 | $70.8K | 0 |
| Jun 6, 2025 | Seshadri Vishwas | Chief Executive Officer | Sell | 50,676 | $6.76 | $342.6K | 0 |
| Jun 6, 2025 | Vazzano Joseph Walter | Chief Financial Officer | Sell | 17,795 | $6.76 | $120.3K | 0 |
| Jun 1, 2025 | Seshadri Vishwas | Chief Executive Officer | Sell | 885 | $6.24 | $5.5K | 0 |
| May 27, 2025 | Alvino Mark | Director | Sell | 2,000 | $6.38 | $12.8K | 0 |
| May 16, 2025 | Alvino Mark | Director | Sell | 8,000 | $5.68 | $45.4K | 0 |
| Mar 31, 2025 | Seshadri Vishwas | Chief Executive Officer | Sell | 25,000 | $4.78 | $119.5K | 0 |
| Mar 14, 2025 | Vazzano Joseph Walter | Chief Financial Officer | Sell | 685 | $5.29 | $3.6K | 0 |
| Mar 3, 2025 | O'Malley Brendan M. | SVP, General Counsel | Sell | 181 | $5.24 | $948.44 | 0 |
| Jan 29, 2025 | Alvino Mark | Director | Sell | 4,000 | $5.38 | $21.5K | 0 |
| Jan 21, 2025 | Alvino Mark | Director | Sell | 4,000 | $5.10 | $20.4K | 0 |
| Oct 16, 2024 | Seshadri Vishwas | Chief Executive Officer | Sell | 251 | $6.54 | $1.6K | 0 |
| Sep 28, 2024 | O'Malley Brendan M. | SVP, General Counsel | Sell | 6,579 | $5.89 | $38.8K | 0 |
ABEO Insiders
Vazzano Joseph Walter
officer: Chief Financial Officer
Bought $39.1KSold $1.06M
19 tradesLast: Jun 9, 2026
Seshadri Vishwas
director, officer: Chief Executive Officer
Bought $201.2KSold $2.78M
22 tradesLast: Jun 9, 2026
Similar Stocks to ABEO
VRTX
Vertex Pharmaceuticals Incorporated
$445.21+0.04%
$113.41B
REGN
Regeneron Pharmaceuticals, Inc.
$614.20+0.45%
$65.47B
ALNY
Alnylam Pharmaceuticals, Inc.
$283.35-2.09%
$40.46B
RVMD
Revolution Medicines, Inc.
$153.65+2.96%
$31.73B
UTHR
United Therapeutics Corporation
$542.43-0.54%
$23.12B
INSM
Insmed Incorporated
$98.28+1.64%
$20.41B
INCY
Incyte Corporation
$108.85+0.95%
$20.11B
MRNA
Moderna, Inc.
$50.18+1.06%
$18.89B